Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant rh-Endostatin in Stage IB NSCLC
NCT02001168Phase 3Unknown
- Sponsor
- Xinjiang Medical University
- Start
- Oct 2013
- Primary completion
- Dec 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Xinjiang Medical University. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02001168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02001168.